Risks of PSA Screening Now Better Understood
نویسندگان
چکیده
منابع مشابه
PSA Screening in Prostate Cancer
Introduction: Prostate cancer is one of the most common cancers in Iranian men. PSA(prostate specific antigen) screening is a controversial issue because PSA screening leads to diagnose of patients with low risk prostate cancer who not only do not benefit from treatment but also suffer from complication caused by treatment. On the other hand, without prostate cancer screening, the rate of meta...
متن کاملExploring patient perceptions of PSA screening for prostate cancer: risks, effectiveness, and importance.
OBJECTIVE To study the beliefs of a group of Canadian men regarding the risks, effectiveness, and importance of routine prostate-specific antigen (PSA) testing when used as a screening tool for prostate cancer. DESIGN A 1-page questionnaire designed to gauge patient beliefs about PSA screening. SETTING Two primary care clinics in Kingston, Ont. PARTICIPANTS Seventy-two men aged 41 to 80. ...
متن کاملPSA screening for prostate cancer.
Screening of prostate cancer with prostate-specific antigen (PSA) is a highly controversial issue. One part of the controversy is due to the confusion between population screening and early diagnosis, another derives from problems related to the quality of existing screening studies, the results of radical curative treatment for low grade tumors and the complications resulting from treatments t...
متن کاملPSA Screening for Prostate Cancer.
Narrative: U.S. men have a 16% chance of a prostate cancer diagnosis in their lifetime and a 3% chance of dying from prostate cancer.1 Autopsy studies have shown that up to two-thirds of older men die with asymptomatic prostate cancer. It appears that most men will develop prostate cancer if they live long enough, although it usually does not affect longevity.1 Given the high incidence of prost...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JNCI Journal of the National Cancer Institute
سال: 2013
ISSN: 0027-8874,1460-2105
DOI: 10.1093/jnci/djt328